Atlas Trials

Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+Goserelin

Clinical trial NCT05004142 · UNKNOWN

Trial details

NCT number
NCT05004142
Sponsor
Ahon Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2020-06-30
Primary completion
2021-12-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.